STNT — Stevia Nutra Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Stevia Nutra Corp. is a Canada-based advanced technology company developing advanced tech in health, energy, and sustainability. The Company is actively engaged in developing and researching solutions in its verticals: health, energy, and technology. Under Health Tech, the Company is seeking FDA approval for Phase I testing of a medical device, WSJ-B Type Spin Magnetic Diabetes Treatment Instrument, which is developed by Hai Nan Taihe Medical Technology Ltd. This apparatus utilizes electromagnetic therapy to assist in the rehabilitation of diabetes and its complications, offering treatment option for those managing Type II diabetes.
Directors
- Brian Dicks PRE (55)
- Hilary Rodrigues CEO (69)
- David Foo VOP (32)
- Ahmed Attia El Sheikh OTH (40)
- Robert Dicks SEC (49)
- Ian Bowmer DRC
- Last Annual
- Last Interim
- Incorporated
- April 30th, 2010
- Public Since
- July 6th, 2011
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 25,514,989
- Address
- 37 Bannisters Rd, CORNER BROOK, A2H 1M5
- Web
- Phone
- +1 7096603056
- Contact
- Brad Long
- Auditors
Similar to STNT
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 23:26 UTC, shares in Stevia Nutra are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Stevia Nutra last closed at $0.00 and the price had moved by -100% over the past 365 days. In terms of relative price strength the Stevia Nutra share price has underperformed the S&P500 Index by -100% over the past year.
There is no consensus recommendation for this security.
Find out moreStevia Nutra does not currently pay a dividend.
Stevia Nutra does not currently pay a dividend.
Stevia Nutra does not currently pay a dividend.
To buy shares in Stevia Nutra you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Stevia Nutra had a market capitalisation of .
Here are the trading details for Stevia Nutra:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: STNT
Based on an overall assessment of its quality, value and momentum Stevia Nutra is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Stevia Nutra. Over the past six months, its share price has underperformed the S&P500 Index by -100%.
As of the last closing price of $0.00, shares in Stevia Nutra were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Stevia Nutra PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Stevia Nutra's management team is headed by:
- Brian Dicks - PRE
- Hilary Rodrigues - CEO
- David Foo - VOP
- Ahmed Attia El Sheikh - OTH
- Robert Dicks - SEC
- Ian Bowmer - DRC